Skip to content

4Accepted Oct 5, 2:29 PM ET

Procter & Gamble Co: health care CEO Gama Paul received 12,517 shares

PGPROCTER & GAMBLE Co

Accepted (ET)

2:29 PM

Oct 5, 2026

Filed

Oct 5, 2026

Documents

1

Size

5.5 KB

Summary

Procter & Gamble Co: health care CEO Gama Paul received 12,517 shares

Updated

What happened Gama Paul, health care CEO, received 12,517 shares as restricted stock units on Oct 1, 2026, at $0.00 per share for a total value of $0.

Key details

  • Transaction date and price: Oct 1, 2026; $0.00 per share, total $0.
  • Shares owned after the transaction: not reported in the filing.
  • Footnote F1: "Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan."
  • Filing timeliness: not indicated in the filing.

Why it may matter This was an award/grant of restricted stock units, not a market purchase or sale. This filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing